Evidence map›Paper›PMID 25691744›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Cell-specific proteomic analysis in Caenorhabditis elegans.

Kai P Yuet, Meenakshi K Doma, John T Ngo, Michael J Sweredoski, Robert L J Graham, Annie Moradian, Sonja Hess, Erin M Schuman, Paul W Sternberg, David A Tirrell

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Single-tissue proteomics inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. MACSPI enables tissue-selective proteomic and interactomic analyses in multicellular organisms.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. iScience · 2023
    Review
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kai P YuetDivisions of Chemistry and Chemical Engineering and.
Meenakshi K DomaBiology and Biological Engineering, Howard Hughes Medical Institute, and.
John T NgoDivisions of Chemistry and Chemical Engineering and.
Michael J SweredoskiProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125; and.
Robert L J GrahamProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125; and.
Annie MoradianProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125; and.
Sonja HessProteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125; and.
Erin M SchumanMax Planck Institute for Brain Research, D-60528 Frankfurt am Main, Germany.
Paul W SternbergBiology and Biological Engineering, Howard Hughes Medical Institute, and.
David A TirrellDivisions of Chemistry and Chemical Engineering and tirrell@caltech.edu.
California Institute of Technology · USHoward Hughes Medical Institute · USMax Planck Institute for Brain Research · DE

Funding

NEW AMINO ACIDS FOR PROTEIN ENGINEERINGR01GM062523 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI TIRRELL, DAVID A · 2001 to 2013
$3.6M
Purchase of a Liquid Chromatograph-Orbitrap VELOS mass spectrometerS10RR029594 · NCRR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HESS, SONJA · 2011 to 2011
$600k
Howard Hughes Medical InstituteNCRR NIH HHS 1S10RR029594-01A1NCRR NIH HHS S10 RR029594NIGMS NIH HHS R01 GM062523
6 · The paper itself

Abstract

Proteomic analysis of rare cells in heterogeneous environments presents difficult challenges. Systematic methods are needed to enrich, identify, and quantify proteins expressed in specific cells in complex biological systems including multicellular plants and animals. Here, we have engineered a Caenorhabditis elegans phenylalanyl-tRNA synthetase capable of tagging proteins with the reactive noncanonical amino acid p-azido-L-phenylalanine. We achieved spatiotemporal selectivity in the labeling of C. elegans proteins by controlling expression of the mutant synthetase using cell-selective (body wall muscles, intestinal epithelial cells, neurons, and pharyngeal muscle) or state-selective (heat-shock) promoters in several transgenic lines. Tagged proteins are distinguished from the rest of the protein pool through bioorthogonal conjugation of the azide side chain to probes that permit visualization and isolation of labeled proteins. By coupling our methodology with stable-isotope labeling of amino acids in cell culture (SILAC), we successfully profiled proteins expressed in pharyngeal muscle cells, and in the process, identified proteins not previously known to be expressed in these cells. Our results show that tagging proteins with spatiotemporal selectivity can be achieved in C. elegans and illustrate a convenient and effective approach for unbiased discovery of proteins expressed in targeted subsets of cells.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGene Expression RegulationIsotope LabelingMutationProteomeProteomicsCaenorhabditis elegans ProteinsProteomecell-specific protein expressionclick chemistrynematode pharyngeal muscleprotein engineeringproteomics

Identifiers

PMID25691744
PMCPMC4352802
OpenAlexW2110062500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.